PE firm InvAscent writes bigger cheques in pharma as rising costs reset capital needs
This comes on the back of increased investor interest in the pharma and healthcare sectors, driven by higher income spends, expanding healthcare coverage and growing medical tourism
This comes on the back of increased investor interest in the pharma and healthcare sectors, driven by higher income spends, expanding healthcare coverage and growing medical tourism
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
